Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report North America Cartilage Repair Market, published by KBV research, the North America Cartilage Repair Market would witness market growth of 7.7% CAGR during the forecast period (2018 – 2024).
The USA market would dominate the North America Fibrocartilage Market by Country by 2024, growing at a CAGR of 7.7 % during the forecast period. The Canada market is expected to witness a CAGR of 10.9% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 9.9% during (2018 - 2024).
The Knee Cartilage Repair market dominated the North America Cartilage Repair Market by Site Outlook in 2017. The Other Site Outlook market is expected to witness a CAGR of 8% during (2018 - 2024).
The Intrinsic Repair Stimulus market dominated the Mexico Cartilage Repair Market by Treatment Type in 2017, and would achieve a market value of $105.4 million by 2024, growing at a CAGR of 8.6 % during the forecast period. The Palliative market is expected to witness highest CAGR of 9.9% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of B. Braun Melsungen AG, Zimmer Biomet, Johnson and Johnson, Smith & Nephew Plc., Stryker Corporation, Vericel Corporation, Osiris Therapeutics Inc., Arthrex, Inc., Collagen Solutions Plc., and Anika Therapeutics, Inc.
North America Cartilage Repair Market Segmentation
By Treatment type
By Site outlook
Unique Offerings from KBV Research